-+ 0.00%
-+ 0.00%
-+ 0.00%

AMPHASTAR PHARMACEUTICALS: ADDITIONAL PAYMENTS TO HANXIN OF UP TO $14 MLN IN DEVELOPMENT MILESTONE PAYMENTS, UP TO $75 MLN IN SALES MILESTONE PAYMENTS

Reuters·01/12/2026 11:03:50

Please log in to view news